Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigious | ||
| Readability |
H.S. freshman Avg
|
|
New words:
Alzheimer, andALTACE, andCALTRATE, andENBREL, andINDERAL, andLBW, andPROMIL, andPROMISE, andPROTONIXnet, asENBREL, asIncome, asPREVNAR, assignee, assignment, asthma, autism, banc, bapineuzumab, Beaumont, biotech, Book, CALTRATE, candidate, Cappel, cardiac, cardiovascular, causation, Centre, chemistry, Coffey, combinedEFFEXOR, complicated, concerningPREMARIN, counter, cyclic, damage, death, decedent, decide, DIMETAPP, directly, disguised, duration, EITF, Elan, en, enacted, enforce, equivalent, ERW, essentially, ethinyl, evaluatingENBREL, evidence, evidentiary, exceed, fall, fibromyalgia, flea, forthNet, forTYGACILfor, GOLD, grown, guardian, hepatic, hereof, Home, hopeful, hostility, IBEP, immunotherapeutic, includingPREMPRO, infection, ingestingEFFEXOR, interlocking, intervened, invention, Israel, iv, ix, Jefferson, Judicial, licensee, litem, liver, maturing, mcg, Meridian, mild, Missouri, MMR, Mo, Mylan, neurological, nonrefundable, Northern, notified, notwithstanding, numeric, Nycomed, ofCavender, ofCENTRUM, ofDean, ofPREMARINandPREMPROand, ofPRISTIQfor, ofPROTONIXto, ofPROTONIXuntil, ofSimon, Ohio, Orange, orPREMARIN, owner, pain, paper, PE, persistent, petitioner, pharmacy, phenylephrine, plc, PM, pose, preliminary, prescribedLYBREL, presided, productsNURSOY, prove, punitive, randomized, ratified, ratio, reclassification, recoupment, reformulation, rehearing, reinspection, rendered, rubella, Sandoz, skin, slower, smaller, Southern, specialty, standing, stopped, strike, successfully, sue, Sun, supermajority, Task, tentatively, thanNet, TheCoffeycase, theory, thimerosal, thromboembolic, tick, toPROTONIX, unsupported, USA, vi, vii, viii, West, WhileNet, withPROTONIX, withstand, Wockhardt, wrongful, xi, Yeda
Removed:
achieve, average, bleeding, capitalized, committee, convene, description, expire, fluctuation, formula, fourth, initial, inPREVNAR, Lupin, margin, method, ofENBRELin, ofLYBREL, portion, postoperative, proposed, represent, responded, stability, succinate, suicidality, tablet, theLYBREL, thePREMARINfamily, weighted, York
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 3.1 the Company's Restated Certificate of Incorporation
- 10.1 Form of Performance Share Award Agreement for Named Executive Officers
- 10.2 Form of Performance Share Award Agreement
- 10.3 Form of Restricted Stock Unit Award Agreement
- 12 Computation of Ratio of Earnings to Fixed Charges
- 31.1 Certification of Disclosure Pursuant to Section 302 Sarbanes-oxley Act of 2002
- 31.2 Certification of Disclosure Pursuant to Section 302 Sarbanes-oxley Act of 2002
- 32.1 Certification Pursuant to 18 Usc Section 1350, Adopted Pursuant to Section 906
- 32.2 Certification Pursuant to 18 Usc Section 1350, Adopted Pursuant to Section 906
Related press release
WYE similar filings
Filing view
External links